TITAN PHARMACEUTICALS INC 4
4 · TITAN PHARMACEUTICALS INC · Filed Feb 11, 2004
Insider Transaction Report
Form 4
BUCALO LOUIS R MD
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2004-02-09$0.59/sh+81,755$48,235→ 431,986 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-02-09−81,755→ 0 totalExercise: $0.59From: 1994-03-09Exp: 2004-02-09→ Common Stock (81,755 underlying)
Footnotes (1)
- [F1]Not applicable.